Home
Orion Pharma

Orion Pharma Market Share Analysis for August 2026

orion is a globally operating finnish pharmaceutical company – a builder of well-being. we develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients.

Health > Biotechnology and Pharmaceuticals

Domainorionpharma.com

Year Founded--

Employees1001 - 5000

Annual Revenue--

Orion Pharma

Orion Pharma (including company regionals)

orionpharma.com

See more website traffic and engagement information

Total visits to Orion Pharma's top domains

Understand Orion Pharma market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

orionpharma.com59.6K

See more with Sales Intelligence

Avg. visit duration in Orion Pharma's top domains

Analyze Orion Pharma engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

orionpharma.com00:05:17

See more with Sales Intelligence

Avg. pageviews on Orion Pharma's top domains

See how Orion Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

orionpharma.com3.39

See more with Sales Intelligence

Orion Pharma top competitors by domain

Top similar sites in August 2026, ranked by their affinity

sanofi.usCompany NameSanofiEmployees> 10001HQFrance, ParisAnnual revenue> $1BTotal visits73.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Orion Pharma

These are the website technologies, by industry, used by Orion Pharma top domains

Payment & Currencies (5)

Cart Functionality

Advertising (4)

Google Adsense

Marketing (3)

Google Marketing Platform

Mobile (3)

Meta Viewport

More Technologies

9

See all

News & Signals from Orion Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOrion Corporation partnered with Shilpa Medicare Limited on Jul 6th '26.Orion Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market.

NewsShilpa Biologicals Private Limited partnered with Orion Corporation on Jun 30th '26.The rally came after the diversified pharmaceutical and biotechnology company announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited (Shilpa Biologicals), had entered into a co-development and supply agreement with Orion Corporation for an intravenous (IV) nivolumab biosimilar referencing one of the world's most widely used cancer immunotherapies, according to an exchange filing.

NewsOrion Corporation attended event American Society of Clinical Oncology (ASCO(R) Annual Meeting on May 29th '26.Today, Orion Pharma (Orion Corporation) announced that it for the first time will present clinical data from the ongoing Phase 1/2 TEADES trial evaluating ODM-212, an investigational oral small-molecule pan-TEAD inhibitor, at the American Society of Clinical Oncology (ASCO(R) Annual Meeting, taking place May 29 - June 2, 2026, in Chicago, USA.